Qualigen Therapeutics (QLGN) announced they will be the first investors participating in the 2025 bridge round of funding for NanoSynex.

CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the "Company”)announced today ...

Long-term business success is more a function of founder characteristics than the quality of the idea, or resources available ...

Bookshop, a site that lets independent, bricks-and-mortar bookshops sell their books online, is launching an app that will ...

Becca Rubenfeld and the AnchorWatch team recently unveiled a first-of-its-kind bitcoin custody plus insurance solution, which ...

Forget coding in garages — a growing number of entrepreneurs are skipping the start-up grind and buying existing businesses ...

Azercell Telecom” LLC, in partnership with the ADA University Foundation, is excited to announce the launch of the next phase ...

Maryam Hassani’s commitment to leveling the playing field in technology was the primary incentive for her to build Zealous, ...

Here's how you can defeat the overthinker's paradox: To avoid over-complicating projects, aim to create your first version, ...